Recently, the Ministry of Health issued Official Dispatch No. 5946/BYT-DP regarding the projected allocation of COVID-19 vaccines through the end of 2021 for 63 provinces and cities, units, ministries, and sectors. Accordingly, in 2021, the Ministry of Health plans to allocate vaccines to reach a coverage rate of 90% for individuals aged 18 and older, with Hanoi and Ho Chi Minh City projected to receive the highest allocation rate of 99%.
To date, six COVID-19 vaccines have been licensed for use in Viet Nam by the Ministry of Health. Each COVID-19 vaccine offers varying degrees of protective efficacy against the disease.
Below is essential information regarding several COVID-19 vaccines currently being administered in Viet Nam. This document was developed based on the COVID-19 Vaccine Vaccination Practice Guidelines Handbooks of the National Expanded Programme on Immunisation.
Pfizer/BioNTech Comirnaty Vaccine
The Pfizer/BioNTech vaccine has been authorized for use in 111 countries and territories and included in the World Health Organization's emergency use listing. To date, this vaccine has been administered in 97 countries with approximately 850 million doses delivered.
The Comirnaty vaccine has been conditionally approved by the Ministry of Health to meet urgent requirements in the prevention and control of the COVID-19 pandemic. Viet Nam has received a total of 746,460 doses of the Pfizer vaccine and is currently rolling out vaccination.
